Abstract
Cardiovascular disease is one major cause of mortality and morbidity after renal transplantation. Management of arterial hypertension as one important risk factor is a complex problem in the ambulatory care for these patients. Offical therapeutical recommendations are vague and due to the lack of randomized controlled and prospective studies generally based on experiences in nontransplanted patient populations. New insights into different pathogenetic mechanisms have increased the awareness of transplant researchers for alternate therapeutical strategies in this patient cohort.
Keywords: Posttransplant hypertension, target blood pressure, immunosuppression, calcineurin inhibitors, renin angiotensin system
8